Paula Landman

Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series

Y. Whang, P. Googe, F. Collichio, 2019, Journal of Immunotherapy for Cancer.